Open AccessPatterns and predictors of cancer‐specific patient health portal usage among patients with cancer: results from the UWCCC Survivorship Program
Author(s) -
Luoh Rebecca P.,
Tevaarwerk Amye J.,
Chandereng Thevaa,
Smith Elena M.,
Carroll Cibele B.,
Emamekhoo Hamid,
Sesto Mary E.
Publication year - 2021
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.4234
Subject(s) - medicine , patient portal , cancer , residence , psychological intervention , family medicine , demographics , odds ratio , disease , survivorship curve , health care , odds , liver cancer , oncology , logistic regression , nursing , demography , sociology , economics , economic growth
Abstract Background Portals can assist patients in managing their healthcare. Understanding how patients with cancer use portals can facilitate improvements in patient engagement in cancer care. This study sought to determine if patients with cancer used portals differently for cancer versus noncancer purposes. The effects of geographic residence (rural vs. urban residence) and cancer stage on portal usage were also investigated. Methods We conducted a retrospective analysis of portal usage by patients seen at an NCI‐designated cancer center between 2015 and 2019. Demographics, cancer characteristics, and portal usage (number of successful logins, messages sent, and results viewed) were extracted. Messages sent and results viewed in the portal were deemed oncologist‐specific and cancer specific if sent to or ordered in medical oncology departments, respectively. Results The analysis included a total of 5950 patients with cancer. Patients were less likely to send and view oncologist‐specific messages compared to non‐oncologist‐specific messages. They were also less likely to view cancer results compared to noncancer results. Compared to urban counterparts, patients residing in rural areas had lower odds of having any logins and logged in less frequently during the year of diagnosis. Compared to patients with non‐metastatic disease, individuals with metastatic disease were more likely to become frequent portal users. Conclusions Patients may use portals differently for cancer versus noncancer purposes; urban residence and metastatic cancer were associated with more frequent usage. Further investigation can inform interventions to increase accessibility for groups at a disadvantage related to the use of this technology and to help patients better leverage portals to manage their cancer.